Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce

Novavax still reported bleak first-quarter earnings and revenue that missed Wall Street's estimates.

from Health and Science https://ift.tt/5z2jgAm
https://ift.tt/20TUE5b
https://ift.tt/boAU4ly